Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


The abstract submission system is closed

Abstract submission deadlines


Date and time

Regular abstracts

3 May 2022, 21:00hrs CEST 
 (CEST = Central European Summer Time)

Late-breaking abstracts

9 August 2022, 21:00hrs CEST
 (CEST = Central European Summer Time)

Outcome notifications

Outcome notifications are expected to be made available to first authors by mid-July 2022.

Abstract submission categories

  • Adrenal cancer
  • NSCLC, metastatic
  • Basic science
  • Oesophagogastric cancer 
  • Biliary tract cancer, incl. cholangiocarcinoma
  • Palliative care
  • Biomarkers (agnostic)
  • Pancreatic cancer
  • Breast cancer, early stage
  • Penile cancer
  • Breast cancer, locally advanced
  • Prostate cancer
  • Breast cancer, metastatic
  • Psycho-oncology
  • CNS tumours
  • Public policy
  • Colorectal cancer
  • Renal cancer
  • Developmental therapeutics
  • Sarcoma
  • Endocrine tumours
  • SCLC
  • Germ cell (testicular) cancer
  • Supportive care
  • Gynaecological cancers
  • Thoracic malignancies, other
  • Haematological malignancies
  • Thyroid cancer
  • Head and neck cancer, excluding thyroid
  • Translational research (agnostic)
  • Hepatocellular carcinoma (HCC)
  • Tumour biology and pathology
  • Investigational immunotherapy
  • Urothelial cancer
  • Melanoma and other skin tumours
  • *Cancer nursing: eHealth and digital innovations 
  • Miscellaneous
  • *Cancer nursing: Health promotion, prevention, and screening 
  • Neuroendocrine tumours
  • *Cancer nursing: Palliative and end-of-life care  
  • New diagnostic tools
  • *Cancer nursing: Patient and occupational safety 
  • NSCLC, early stage
  • *Cancer nursing: Professional and educational issues in cancer nursing
  • NSCLC, locally advanced
  • *Cancer nursing: Supportive care and symptom management 

*Abstracts may also be submitted to the Cancer nursing track. Submissions in these categories will be reviewed by the European Oncology Nursing Society (EONS) Scientific Committee for selection and presentation in the EONS cancer nursing programme. Unless otherwise stated, submissions in the Cancer nursing categories must follow all regular ESMO 2022 submission regulations and guidelines.

Late-breaking abstracts (LBA)

Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.

The work must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organisation prior to the ESMO 2022.

A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline on 3 May 2022.

Submitters of preliminary versions receiving approval to proceed must submit the final LBA by 9 August 2022, 21:00 CEST (Central European Summer Time).

Trial in progress abstracts (TiP)

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ESMO 2022.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design

Please note:

  • Recruitment must have already begun or have been completed by the abstract submission deadline of 3 May 2022.
  • Abstracts including results or preliminary data will be rejected.
  • Trial in Progress abstracts can be accepted for Poster presentation only.
  • Encore TiP abstracts will not be accepted.

Publication schedule of accepted abstracts

  1. All regular abstracts accepted for presentation at ESMO 2022 as Proffered Paper (suffix O), Mini Oral (suffix MO), Poster (suffix P or TiP) will be published online via the ESMO website at 00:05 CEST on Monday, 5 September 2022.
  2. All Late-breaking abstracts accepted for presentation at ESMO 2022 as Proffered Paper or Mini Oral (prefix LBA) will be published online via the ESMO website at 00:05 CEST on Thursday, 8 September 2022.
  3. LBA1 and Abstract 903O will be published online via the ESMO website at 00:05 CEST on Friday, 9 September 2022.
  4. LBA10 will be published online via the ESMO website at 00:05 CEST on Monday, 12 September 2022.


Date and time

 Regular abstracts accepted as:

  • Proffered Paper (suffix ‘O’)
  • Mini Oral (suffix ‘MO’)
  • Poster (suffix ‘P’)
  • Poster (suffix ‘TiP’)
  • EONS Poster (prefix ‘CN’)

Monday, 5 September 2022
00:05 Central European Summer Time (CEST)

 All late-breaking abstracts (prefix ‘LBA’)

Thursday, 8 September 2022
00:05 Central European Summer Time (CEST)

 Dedicated embargo for LBA1 and 903O

Friday, 9 September 2022
00:05 Central European Summer Time (CEST)

Dedicated embargo for LBA10

Monday, 12 September 2022
00:05 Central European Summer Time (CEST)

Embargo policy

Data and information included in accepted abstracts is under embargo until the relevant embargo release date cited in the schedule above.

Data and information beyond what is included in all accepted abstracts, for example full data sets, may only be made public at the start of the official programme session during which the study is presented.

Presentation of accepted abstracts

 The ESMO 2022 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

  • Presidential Symposium – Oral presentations by authors presenting cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
  • Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
  • Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.

All accepted abstracts, including late-breaking abstracts, will be published online only in the ESMO 2022 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.

Detailed instructions for the preparation of visual presentations and posters will be made available on the ESMO website by end-July 2022 along with scheduling notices.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.